Table 7 Overview of the protection rate of liver-arresting GAPs in humans

From: The path from early- to late-liver stage arresting genetically attenuated parasites as a malaria vaccination strategy

Author

Parasite

Dose

Challenge

Protection

Spring et al., 201335

PfΔp52Δp36 (2KO)

5 mosquito bites

NA

NA

 

PfΔp52Δp36 (2KO)

200 mosquito bites

NA

NA

Kublin et al., 201741

PfΔp52Δp36Δsap1 (3KO)

150–200 mosquito bites

NA

NA

Murphy et al., 202242

PfΔp52Δp36Δsap1 (3KO)

200 mosquito bites 3 times

(2 immunizations at monthly intervals

and the third 8 weeks later)

5 PfNF54 mosquito bites 4 weeks later

3/6

(50%)

 

NA

NA

5 PfNF54 mosquito bites rechallenge

180 days later

0/3

(0%)

 

PfΔp52Δp36Δsap1 (3KO)

200 mosquito bites 5 times

(4 immunizations at 4-week intervals and the fifth 8 weeks later)

5 PfNF54 mosquito bites 4 weeks later

4/8

(50%)

 

NA

NA

5 PfNF54 mosquito bites rechallenge

180 days later

1/4

(25%)

Roestenberg et al., 202045

PfΔb9Δslarp

(PfSPZ-GA1)

1.35 × 105 cryopreserved sporozoites IV

NA

NA

 

PfSPZ-GA1

4.5 × 105 cryopreserved sporozoites IV

NA

NA

 

PfSPZ-GA1

9 × 105 cryopreserved sporozoites IV

NA

NA

 

PfSPZ-GA1

4.5 × 105 cryopreserved sporozoites IV three time at 2-month intervals

5 PfNF54 mosquito bites 3 weeks later

1/12

(8%)

 

PfSPZ-GA1

9 × 105 cryopreserved sporozoites IV 3 times at 2-month intervals

5 PfNF54 mosquito bites 3 weeks later

2/13

(15%)

Lamers et al., 202451

PfΔmei2 (GA2)

15 mosquito bites

NA

NA

 

PfΔmei2 (GA2)

50 mosquito bites

NA

NA

 

PfΔb9Δslarp (GA1)

50 mosquito bites 3 times at monthly intervals

5 Pf3D7 mosquito bites 3 weeks later

1/8

(13%)

 

PfΔmei2 (GA2)

50 mosquito bites 3 times at monthly intervals

5 Pf3D7 mosquito bites 3 weeks later

8/9

(89%)

Roozen et al., 202552

PfΔmei2 (GA2)

50 mosquito bites

5 Pf3D7 mosquito bites 6 weeks later

9/10

(90%)

  1. IV: intravenous.